TEVA

Teva Pharmaceutical Industries Ltd.

Price

$33.64

return (12m)

103.73% Logo

p/e

22.87

p/bv

4.35

DIVIDEND YIELD

0.00%
graph

TEVA price

Select period
Select period
Teva Pharmaceutical
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment TEVA

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
1.28%
3 months
-4.93%
1 year
103.73%
2 years
96.70%
5 years
248.55%
10 years
-34.12%
Fundamental indicators

Fundamentals TEVA

Check the fundamentals of Teva Pharmaceutical shares.

Valuation

P/E
22.87
Sector -4.01
Industry -4.01
P/BV
4.35
Sector 2.04
Industry 2.04
P/Revenue (PSR)
2.06
Sector -4.26
Industry -4.26
EV/EBITDA
52.50
Sector -238.23
Industry -238.23
EV/EBIT
72.17
Sector -670.51
Industry -670.51
P/EBITDA
10.94
Sector -4.23
Industry -4.23
P/EBIT
15.75
Sector -4.26
Industry -4.26
P/Total Assets
0.89
Sector 1.45
Industry 1.45
P/Net Current Assets
-1.98
Sector -11.50
Industry -11.50
P/Working Capital
200.97
Sector -11.36
Industry -11.36
EPS
1.35
Sector -2.20
Industry -2.20
BVPS
7.12
Sector 1.95
Industry 1.95

Efficiency

Gross Margin
52.08%
Sector 36.28%
Industry 36.28%
EBITDA Margin
22.03%
Sector -16,822.56%
Industry -16,822.56%
EBIT Margin
16.03%
Sector -4,238,732.42%
Industry -4,238,732.42%
Operating Margin
23.07%
Sector -38.78%
Industry -38.78%
Net Profit Margins
9.02%
Sector -39.92%
Industry -39.92%
Asset Turnover
0.10
Sector 0.03
Industry 0.03

Profitability

ROE
19.00%
Sector -65.93%
Industry -65.93%
ROA
3.91%
Sector -66.10%
Industry -66.10%
ROIC
7.38%
Sector -2,918.81%
Industry -2,918.81%

Dividends

Dividend yield
0.00%
Sector -
Industry -
Payout
0.00%
Sector -
Industry -

Debt

Current Ratio
1.01
Sector 2.91
Industry 2.91
Net Debt / EBITDA
11.71
Sector -13,526,126.12
Industry -13,526,126.12
Net Debt / EBIT
16.10
Sector -3.66
Industry -3.66
Net Debt / Equity
1.25
Sector -1.10
Industry -1.10
Gross Debt / Equity
1.70
Sector -0.10
Industry -0.10
Equity/Assets
0.21
Sector 0.42
Industry 0.42
Liabilities/Assets
0.79
Sector 0.39
Industry 0.39

Growth

5Y Revenue CAGR
1.79%
Sector -
Industry -
5Y Earnings CAGR
30.26%
Sector -
Industry -
RETORNO DO INVESTIMENTO

FAIR VALUE OF Teva Pharmaceutical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$33.64

Fair Value

$14.71

Upside Return potential.

-56.28%
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
Histórico de indicadores fundamentalistas

Fundamentals TEVA

Buy And Hold Investor Checklist

Teva Pharmaceutical Buy And Hold Investor Checklist

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

TEVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd.

Average Investor10 user rating

4.0 (10 people)

United States

United States

82 years

Founded: 1944

1990

Time since IPO - 36 years

40.216

Employees

Market cap

$35.77 billion

$35.77 billion

Net worth

$8.23 billion

$8,232,000,000.00

Assets

$40.04 billion

$40,040,000,000.00

Total Shares Outstanding

1.16 billion

1,156,000,000

Average Daily Trading Volume

$5.57 million

$5,568,235.18

Sector

Health Care

Industry

Biotechnology

Shares

receitas e lucros

TEVA revenue and profits

graph

PROFIT X PRICE TEVA

Financials

Financial Results TEVA

DRAG THE FRAME TO SEE MORE DATA
Financials

TEVA cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - TEVA

Pontos Relevantes

TEVA balance sheet

DRAG THE FRAME TO SEE MORE DATA

Frequently Asked Questions

What is the price of Teva Pharmaceutical (TEVA) today?

A cotação de Teva Pharmaceutical (TEVA) hoje está em US$ 33.64, com uma variação de 103.73% em relação ao último ano. A cotação de Teva Pharmaceutical (TEVA) iniciou o ano negociando na casa dos US$ 31.21 e hoje está em US$ 33.64. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Teva Pharmaceutical (TEVA) e dados de ações do Ibovespa e mercados internacionais.

Quando Teva Pharmaceutical (TEVA) paga dividendos?

Teva Pharmaceutical (TEVA) não distribuiu dividendos no último ano.

Is Teva Pharmaceutical (TEVA) a good investment?

Atualmente, Teva Pharmaceutical (TEVA) está cotada a US$ 33.64, com um P/L de 22.87, representando um desvio de 159% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 103.73 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 103.73%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Teva Pharmaceutical (TEVA) stock?

Investir em ações de Teva Pharmaceutical (TEVA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Teva Pharmaceutical (TEVA) yield today?

A rentabilidade de Teva Pharmaceutical (TEVA) foi de 1.28% no último mês, 103.73% no último ano e 248.55% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Teva Pharmaceutical (TEVA) hoje, o investimento total seria de US$ 3,363.50, com base na cotação atual de US$ 33.64.

Based on historical performance, the investment would have grown to approximately:

  • Em 1 ano: US$ 6,852.46
  • Em 5 anos: US$ 11,723.48
  • Em 10 anos: US$ 2,215.87

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.